Skip to main content

Advertisement

Log in

Molecular mimicry in neurological disease: what is the evidence?

  • Review
  • Published:
Cellular and Molecular Life Sciences Aims and scope Submit manuscript

Abstract.

Autoimmune diseases are a leading cause of disability and are increasing in incidence in industrialized countries. How people develop autoimmune diseases is not completely understood, but is related to an interaction between genetic background, environmental agents, autoantigens and the immune response. Molecular mimicry continues to be an important hypothesis that explains how an infection with an environmental agent results in autoimmune disease of the nervous system and other target organs. Although molecular mimicry has yet to be unequivocally proven, in the past several years there has been a sharpening of its definition with better experimental data implicating it as a cause of neurological disease in humans.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. C. Levin.

Additional information

Received 9 July 2007; received after revision 15 November 2007; accepted 27 November 2007

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, S., Levin, M.C. Molecular mimicry in neurological disease: what is the evidence?. Cell. Mol. Life Sci. 65, 1161–1175 (2008). https://doi.org/10.1007/s00018-007-7312-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00018-007-7312-7

Keywords.

Navigation